PMID: 8965598Jan 1, 1996Paper

DNA content of the tumor cell. A new prognostic parameter in hepatocellular carcinoma?

Langenbecks Archiv für Chirurgie
T C BöttgerT Junginger

Abstract

Hepatocellular carcinoma is a heterogeneous disease with considerable differences in malignant behaviour. Some relevant factors for prognosis are known. In this study we analysed DNA ploidy as a potential prognostic parameter. With DNA image cytometry we were able to differentiate between diploid, hypotriploid, triploid, hypertriploid, tetraploid and aneuploid tumours. The best prognosis was for patients with diploid, hypotriploid and tetraploid tumours with a median survival time of 41 months in contrast to 3 months for patients with triploid, hypertriploid or aneuploid tumours. There was a strong correlation between histomorphological parameters and the DNA content. The DNA content of tumour cells may be considerable clinical relevance in hepatocellular carcinoma regarding the decision as to whether or not to perform a resection. In patients with prognostically unfavorable parameters adjuvant oncological therapy may improve the prognosis.

References

Jul 1, 1992·The British Journal of Surgery·N NagasueT Nakamura
Sep 1, 1992·Journal of Hepatology·N NagasueT Nakamura
Feb 15, 1991·Cancer·J FujimotoM Mitsunobu
Apr 1, 1986·World Journal of Surgery·H BismuthF Meriggi
Jul 1, 1994·American Journal of Clinical Pathology·I O NgM K So
Jan 1, 1994·Langenbecks Archiv für Chirurgie·J ZierenJ M Müller
Mar 1, 1994·Annals of Surgery·D G FarmerR W Busuttil
Jan 1, 1993·Journal of Surgical Oncology. Supplement·K Okuda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.